WED-111 Plasma proteomics uncovers progression markers of acute-onchronic liver failure
Florian A. Rosenberger(Max Planck Institute of Biochemistry), Matthias Mann(Max Planck Institute of Biochemistry), Jonel Trebicka(Klinik für Schlafmedizin), Dávid Tornai(Beth Israel Deaconess Medical Center), Robert Schierwagen(University of Münster), Rajiv Jalan(Roland Hill (United Kingdom)), Vincent Albrecht(Science for Life Laboratory), Minneke J. Coenraad(Leiden University Medical Center), Maximilian Zwiebel(Wellcome Sanger Institute), Frank Erhard Uschner(Goethe University Frankfurt), Wim Laleman(University Hospital Münster), Peter V. Treit(Max Planck Institute of Biochemistry), Mária Papp(University of Debrecen), Joan Clària(European Foundation for the Study of Chronic Liver Failure), Wenyi Gu, Debbie L. Shawcross(King's College - North Carolina)
Cited by 0
Related Papers
MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification
|Nature Biotechnology|2008|15.7k
The Perseus computational platform for comprehensive analysis of (prote)omics data
|Nature Methods|2016|8.9k
Andromeda: A Peptide Search Engine Integrated into the MaxQuant Environment
|Journal of Proteome Research|2011|5.9k
Accurate Proteome-wide Label-free Quantification by Delayed Normalization and Maximal Peptide Ratio Extraction, Termed MaxLFQ
|Molecular & Cellular Proteomics|2014|5.5k